These findings underscore the importance of CXCR4 and JUNB as potential prognostic SCLC biomarkers, in line with previous research linking CXCR4 overexpression to metastasis regulation [68, 69] and to prognostic significance regarding PFS [70] in SCLC patients. Here, CXCR4 is linked to small cell lung carcinoma.